TradeUP Acquisition (UPTD) Stock News, Oct 2022-Jan 2023

Summary not available.

On October 3, 2022, Estrella Biopharma announced a definitive business combination agreement with TradeUP Acquisition Corp. (NASDAQ: UPTD) dated September 30, 2022. This merger will result in Estrella becoming publicly listed as Estrella Immunopharma, Inc. Estrella specializes in CD19-targeted ARTEMIS®️ T-cell therapies for blood cancers and solid tumors, with lead candidates EB103 and EB104. The transaction anticipates a pro forma equity valuation of approximately $398.5 million, with TradeUP's shareholders retaining about 11.1% ownership post-merger. The deal is expected to close in the first half of 2023, pending approvals.